Company intelligence
AABB
Improving lives by making transfusion medicine and biotherapies safe, available, and effective worldwide.
About AABB
Follow this page for information on AABB initiatives and job opportunities. Join the AABB LinkedIn group to connect with like-minded professionals. AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries. Learn more about AABB at www.aabb.org.
Verified activity
Signals from AABB
7 published signals
Products & Services
AABB's cell manufacturing facility produced tisagenlecleucel, the first genetically modified cell therapy product approved by the FDA.
Reported by AABB
Presence & Recognition
AABB recognized Don Siegel, PhD, MD, as the 2026 recipient of the Emily Cooley Memorial Award.
Reported by AABB
People
AABB employee Don Siegel spent 27 years directing Penn’s fellowship program in blood banking/transfusion medicine, training over 40 fellows who have gone on to lead academic blood banks.
Reported by AABB
Presence & Recognition
AABB is submitting proposals for Lightning Talks at Cord Blood Connect 2026, part of the 2026 Annual Meeting in Atlanta.
Reported by AABB
Research & Knowledge
AABB Clinical Transfusion Medicine Committee published an annual review of the year's most significant advances in transfusion medicine and biotherapies, covering blood component therapy, donor screening, patient blood management, hemoglobinopathies, apheresis, biotherapies, and health care disparities.
Reported by AABB
Research & Knowledge
AABB published Association Bulletin #26-04 offering recommendations to help hospital transfusion services and blood suppliers recognize and manage transfusion-related alpha-gal syndrome (TRAGS).
Reported by AABB
Presence & Recognition
AABB announced that the 2026 Annual Meeting will feature more than 125 sessions covering blood banking, transfusion medicine, and biotherapies.
Reported by AABB